In this sense, it is a peptide that inhibits the JNK-JIP interaction (type IV JNK inhibitor) with a reported anti-apoptotic effect in cochlear neurons [198] that was also evaluated in labyrinthitis [199] and acute inflammatory bowel disease in vivo models [200]. Here, MAPK8 is linked to labyrinthitis.